No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.

Dana J Lukin Gabriela Funez-dePagnier Svetlana Lima Daniel Lai Lucia Duenas-Bianchi Waseem Ahmed Vinita Jacob Robert Battat Ellen Scherl Randy S Longman

Clin Gastroenterol Hepatol

Jill Roberts Center for Inflammatory Bowel Disease, New York, New York; New York Presbyterian Hospital, Weill Cornell Medical Center, New York, New York; Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York; Jill Roberts Institute for Research in IBD, Weill Cornell Medicine, New York, New York. Electronic address:

Published: November 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178538	PMC
http://dx.doi.org/10.1016/j.cgh.2021.06.008	DOI Listing

Publication Analysis

Top Keywords

durable impact

impact covid-19

covid-19 intestinal

intestinal disease

disease activity

activity subjects

subjects ibd

durable

covid-19

intestinal

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!